#USA #Fairfax #GammaTile #GT Medical Technologies #Inova Fairfax

GT Medical Technologies Announces New GammaTile® Center of Excellence Designation

On May 6, 2025, GT Medical Technologies, a pioneering medical device company with a mission to enhance the lives of brain tumor patients, proudly announced the designation of Inova Fairfax Hospital as a new GammaTile® Center of Excellence. This significant achievement highlights the hospital's commitment to excellence in patient care and innovation in brain tumor treatment.

GammaTile®, an advanced treatment option, offers unique benefits for patients undergoing surgery for brain tumors. Unlike traditional radiation therapy, which often requires a waiting period to allow for healing after surgery, GammaTile provides immediate, targeted radiation directly within the surgical cavity at the time of tumor removal. This innovative approach aims to deliver effective treatment when cancer cells are most vulnerable, thereby minimizing the risk of regrowth and improving overall outcomes for patients.

Inova Fairfax Hospital has demonstrated its proficiency in the GammaTile procedure by meeting stringent clinical criteria and educational standards, asserting its status as a leader in the field. The medical team at Inova encompasses various specialists, including neurosurgeons and radiation oncologists, all working collaboratively to enhance patient care and outcomes.

Dr. Mateo Ziu, Medical Director of the Brain and Spine Tumor Program at Inova Fairfax, expressed pride in receiving this designation. He stated, "Receiving this designation reinforces our dedication to putting the patient at the center, with physicians from different specialties coming together to determine the best way forward. We're proud to offer GammaTile as an advanced treatment that can help brain tumor patients who seek care here at Inova. We will always challenge ourselves to bring the newest technology that will provide the best treatments and outcomes for our patients."

Inova Fairfax’s designation is one of the latest in a series of recognitions granted to healthcare institutions that excel in treating brain tumors with GammaTile®. This program denotes a commitment to rigorous clinical practice and an ongoing passion for pushing the boundaries of what is possible in patient care.

The GammaTile device itself consists of a bioabsorbable collagen implant infused with radiation seeds, strategically placed to deliver targeted therapy directly to the tumor site. With its FDA clearance, GammaTile has gained traction across more than 100 leading centers since its market launch in March 2020, highlighting its expanding role in both academic and community healthcare settings.

GT Medical Technologies was founded by an accomplished team of brain tumor specialists aiming to address unmet needs in this critical area of healthcare. Their dedication lies in advancing treatment options and improving the quality of life for patients affected by brain tumors.

The recognition of Inova Fairfax Hospital as a GammaTile Center of Excellence signifies not only the capabilities of the institution but also the transformative power of innovative medical technologies in the realm of oncology. As the landscape of brain tumor treatments continues to evolve, initiatives like the GammaTile program promise to shape the future of patient care with an emphasis on immediate and efficacious treatment methodologies.

For further information about GammaTile and its benefits, you can visit gammatile.com and stay updated on their social media channels including Facebook, Instagram, LinkedIn, and X.